MAPT and supranuclear palsy, progressive, 1: Considering risk factors other than MAPT, Kouri et al. [90] performed a genome-wide association study (GWAS) of 152 pathologically confirmed CBD cases and identified SNPs at 3p22 MOBP, showing another genetic risk factor shared by CBD and PSP.